Showing results (271-280 of 936) with videos related to

Sort By:
Pageof 94
Human Gene Therapy|October 21, 2011
Pseudotype-independent nonspecific uptake of gammaretroviral and lentiviral particles in human cellsChristine Voelkel, Melanie Galla, Philip N Dannhauser, et al.
Scientific Reports|April 12, 2014
Non-integrating gamma-retroviral vectors as a versatile tool for transient zinc-finger nuclease deliverySylwia Bobis-Wozowicz, Melanie Galla, Jamal Alzubi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 4, 2004
Simplified generation of high-titer retrovirus producer cells for clinically relevant retroviral vectors by reversible inclusion of a lox-P-flanked marker geneRainer Loew, Nathalie Selevsek, Boris Fehse, et al.
Blood|July 11, 2006
Cell-culture assays reveal the importance of retroviral vector design for insertional genotoxicityUte Modlich, Jens Bohne, Manfred Schmidt, et al.
Molecular Therapy. Methods & Clinical Development|October 27, 2021
Safety and efficacy of an engineered hepatotropic AAV gene therapy for ornithine transcarbamylase deficiency in cynomolgus monkeysJulien Baruteau, Sharon C Cunningham, Berna Seker Yilmaz, et al.
Scientific Reports|August 30, 2017
Erratum: Lentiviral vectors can be used for full-length dystrophin gene therapyJohn R Counsell, Zeinab Asgarian, Jinhong Meng, et al.
Scientific Reports|March 3, 2017
Lentiviral vectors can be used for full-length dystrophin gene therapyJohn R Counsell, Zeinab Asgarian, Jinhong Meng, et al.
Scientific Reports|March 18, 2017
Lentiviral vectors can be used for full-length dystrophin gene therapyJohn R Counsell, Zeinab Asgarian, Jinhong Meng, et al.
Pageof 94